Jun 11, 2009 by Brian Orelli, PhDKids, Take Your Antipsychotics!Drugs to combat mental illness might gain FDA approval for children.
Jun 11, 2009 by Brian Orelli, PhDThe FTC Hates You, TooThe agency weighs in (unhappily) on follow-on biologics.
Jun 10, 2009 by Brian Orelli, PhDUp 58% on No News? What's Going On?Volatility is still here for some companies.
Jun 8, 2009 by Brian Orelli, PhDFor the RECORD ...… Avandia's not going to make a comeback for GlaxoSmithKline.
Jun 5, 2009 by Brian Orelli, PhDThe Wrong Way to Invest in the Right StocksExchange-traded funds don't work for this industry.
Jun 4, 2009 by Brian Orelli, PhDMegaMergers Going to the DogsSell before adding? I guess if you have to.
Jun 3, 2009 by Brian Orelli, PhDNo More Triple-Digit Returns?The lid on the black box might be coming off.
Jun 1, 2009 by Brian Orelli, PhDGoing Up for All the Wrong ReasonsMystery bidder identified. So what?
May 29, 2009 by Brian Orelli, PhDThe "Naughty List" You Want Your Company OnImagine if Santa came a week late.
May 29, 2009 by Brian Orelli, PhDThis Company Is Hot and Going PlacesPharma's coveting them right and left.
May 29, 2009 by Brian Orelli, PhDDelayed, Reason UnknownJohnson & Johnson and Bayer can catch up, though.
